Trasylol Recall - Recall by Bayer Could Have Saved Thousands of Lives
Thursday, February 28th, 2008 Medical researcher Dr. Dennis Mangano concluded in a recent report that the delayed recall of the Bayer drug Trasylol caused the death of approximately 22,000 people. Trasylol is a drug that is used during open-heart surgery to stem bleeding and as many as one third of all heart bypass patients in the United States were given Trasylol during the peak of its use by doctors.
Dr. Mangano’s study (published in January of 2006) showed that the medicine can cause kidney failure and increased death in its patients. The Food and Drug Administration advisory panel discussed the study and its findings at their September 2006 meeting but declined to recall Trasylol. Dr. Mangano alleges that this is at least in part because Bayer did not tell the FDA the serious side effects of Trasylol had also been found in Germany.
Trasylol was finally recalled last November, and for many the delay was a death sentence. If the FDA had voted to recall Bayer’s Trasylol at that meeting in 2006, or if Bayer had issued a voluntary recall in light of the negative findings, more than 20,000 lives could have been saved. Bayer is currently facing product-liability lawsuits from victims and families of victims of Trasylol. If you or someone you love has been exposed to Trasylol, contact the lawyers at the law firm of Cappolino Dodd Krebs LLP at 1-800-460-0606 for legal counsel as soon as possible.